The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Abstract
This paper describes the AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG). The questionnaires were administered to 75 patients at ten AACTG sites in the USA. All patients were taking combination antiretroviral therapy (ART), including at least one protease inhibitor. Eleven per cent of patients reported missing at least one dose the day before the interview, and 17% reported missing at least one dose during the two days prior. The most common reasons for missing medications included 'simply forgot' (66%) and a number of factors often associated with improved health, including being busy (53%), away from home (57%) and changes in routine (51%). Less adherent patients reported lower adherence self-efficacy (p = 0.006) and were less sure of the link between non-adherence and the development of drug resistance (p = 0.009). They were also more likely to consume alcohol, to be employed outside the home for pay and to have enrolled in clinical trials to gain access to drugs (all p < 0.05). Twenty-two per cent of patients taking drugs requiring special instructions were unaware of these instructions. Each questionnaire took approximately ten minutes to complete. Responses to the questionnaires were favourable. These questionnaires have been included in six AACTG clinical trials to date and have been widely disseminated to investigators both in the USA and abroad.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The VIRAHEP-C self-efficacy measure was a 24-item self-report measure adapted from previously validated self-efficacy measures created for the Adult AIDS Clinical Trials Group (see Appendix A for the original VIRAHEP-C measure) (19;39) (personal communication, S. Smith, Nov. 11, 2010).”
From Reliability and validity of a self‐efficacy instrument for hepatitis C antiviral treatment regimens (2012) · cites this paper as [39]
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Hesselbart, S., & Fowler, F. J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288598 · Cited by 4,767
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 856
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B. A., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 443
Self-citationPatient Compliance and Drug Failure in Protease Inhibitor Monotherapy
Vanhove, G. F. (1996) · JAMA · doi:10.1001/jama.1996.03540240033024 · Cited by 193
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Besch, C. L. (1995) · AIDS · doi:10.1097/00002030-199501000-00001 · Cited by 148
Predictors of patient adherence: Patient characteristics.
Dunbar, J. (1990) · Cited by 83
Cited by
Sorted by citations
Items 201–300 of 1,001
Protopopescu, C., Raffi, F., Roux, P., Reynes, J., Dellamonica, P., Spire, B., Leport, C., Carrieri, P., & on behalf of the ANRS CO8 (APROCO-COPILOTE) Study Group (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp232 · Cited by 107
Sleep Disturbance and Depression as Barriers to Adherence
Phillips, K. D., Moneyham, L. L., Murdaugh, C. L., Boyd, M. R., Tavakoli, A. S., Jackson, K. L., & Vyavaharkar, M. V. (2005) · Clinical Nursing Research · doi:10.1177/1054773805275122 · Cited by 108
“…and colleagues (2001) found that HIV-infected female patients with symptoms of chronic depression were 2 times more likely to die than patients without depression and displayed a greater decline in CD4 cell count when compared to the patients without depressive symptoms (Chesney et al., 2000).”
Shah, B. B., Walshe, L., Saple, D. G., Mehta, S. H., Ramnani, J. P., Kharkar, R. D., Bollinger, R. C., & Gupta, A. (2007) · Clinical Infectious Diseases · doi:10.1086/513429 · Cited by 108
Kalichman, S. C., Grebler, T., Amaral, C. M., McNerey, M., White, D., Kalichman, M. O., Cherry, C., & Eaton, L. A. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2231-1 · Cited by 107
“We also assessed self-reported adherence at each monthly unannounced phone assessment using a standard measure of 3-day retrospective adherence recall.(23,24) This format for assessing self-reported 3-day adherence has been found reliable and valid.”
MethodHansana, V., Sanchaisuriya, P., Durham, J., Sychareun, V., Chaleunvong, K., Boonyaleepun, S., & Schelp, F. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-617 · Cited by 108
O’Cleirigh, C. M., Ironson, G. H., & Smits, J. A. J. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.11.001 · Cited by 105
“AIDS Clinical Trials Group HIV Symptom Checklist (ACTG; Chesney et al., 2000)—The ACTG questionnaire includes a list of 20 symptoms associated with HIV infection.”
BackgroundMethodInfluentialMeasuring Adherence to Antiretroviral Medications in Clinical Trials
Miller, L. G., & Hays, R. D. (2000) · HIV Clinical Trials · doi:10.1310/enxw-95pb-5ngw-1f40 · Cited by 105
Validity of Medication Adherence Self-Reports in Adults With Type 2 Diabetes
Gonzalez, J. S., Schneider, H. E., Wexler, D. J., Psaros, C., Delahanty, L. M., Cagliero, E., & Safren, S. A. (2012) · Diabetes Care · doi:10.2337/dc12-0410 · Cited by 106
Williams, J. K., Sayles, H. R., Meza, J. L., Sayre, P., Sandkovsky, U., Gendelman, H. E., Flexner, C. W., & Swindells, S. (2013) · Nanomedicine · doi:10.2217/nnm.12.214 · Cited by 104
Rougemont, M., Stoll, B., Elia, N., & Ngang, P. (2009) · AIDS Research and Therapy · doi:10.1186/1742-6405-6-21 · Cited by 103
Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study
Klitzman, R., Kirshenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. Α., Johnson, M. O., Kittel, L., Daya, S., Morin, S. F., Kelly, J. A., et al. (2004) · AIDS Care · doi:10.1080/09540120410001716423 · Cited by 103
Turner, B. J., Hollenbeak, C. S., Weiner, M. G., Have, T. T., & Roberts, C. S. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1766 · Cited by 103
Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users
Carrieri, P., Chesney, M. A., Spire, B., Loundou, A., Sobel, A. T., Lepeu, G., & Moatti, J. (2003) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1001_01 · Cited by 103
Self-citationJohnson, M. O., Carrico, A. W., Chesney, M. A., & Morin, S. F. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.5.829 · Cited by 108
“Antiretroviral medication adherence—Self-reported ART adherence was assessed over a three-day period using an adherence survey developed for use in AIDS Clinical Trials (Chesney et al., 2000).”
MethodSelf-citationCosta, J. D. M., Torres, T. S., Coelho, L. E., & Luz, P. M. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25066 · Cited by 102
“The following standardized instruments were used to measure self-reported adherence: the AIDS Clinical Trials Group (ACTG) adherence instrument [80]; the CAT-VIH - Cuestionario de adherencia al tratamiento para el VIH/SIDA [81]; the CEAT-VIH - Cuestionario para la Evaluaci on de la Adhesi on al Tratamiento Antirretrov…”
MethodSimpler Regimens May Enhance Adherence to Antiretrovirals in HIV-Infected Patients
Maggiolo, F., Ripamonti, D., Arici, C., Gregis, G., Quinzan, G., Antezana, C. G., Ravasio, L., & Suter, F. (2002) · HIV Clinical Trials · doi:10.1310/98b3-pwg8-pmyw-w5bp · Cited by 102
Braithwaite, R. S., & BRYANT, K. J. (2010) · Europe PMC (PubMed Central) · Cited by 101
Pinheiro, C. A. T., de-Carvalho-Leite, J. C., Drachler, M., & da Silveira, V. L. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002001000010 · Cited by 101
“This has been reported by patients as a reason for missing doses (17,21,34).”
BackgroundResultInfluentialGrodensky, C. A., Golin, C. E., Ochtera, R. D., & Turner, B. J. (2012) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2012.73.899 · Cited by 100
Berg, K. M., Litwin, A. H., Li, X., Heo, M., & Arnsten, J. H. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.025 · Cited by 100
“2.9 Additional variables 2.9.1 Self-reported adherence—Baseline self-reported adherence with each antiretroviral medication was assessed using standard questions (Chesney et al., 2000).”
MethodInfluentialIntegrating a web-based, patient-administered assessment into primary care for HIV-infected adults
Fredericksen, R. J. (2012) · Journal of AIDS and HIV Research · doi:10.5897/jahr11.046 · Cited by 100
“Antiretroviral medication adherence: 4-item Adult AIDS Clinical Trial Group (AACTG) instrument (Chesney et al., 2000), a rating scale item (Lu et al., 2008), and a visual analogue scale item (Giordano et al., 2004; Kalichman et al., 2005; Walsh et al., 2002).”
Nam, S. L., Fielding, K., Avalos, A., Dickinson, D., Gaolathe, T., & Geissler, P. W. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.03.042 · Cited by 100
Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence
Moore, D. J., Blackstone, K., Woods, S. P., Ellis, R. J., Atkinson, J. H., Heaton, R. K., Grant, I., & the HNRC Group (2012) · AIDS Care · doi:10.1080/09540121.2012.672718 · Cited by 100
“Medication adherence was evaluated with the AIDS Clinical Trials Group (ACTG) four day adherence self-report questionnaire (Chesney et al., 2000).”
MethodCannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms
Bonn‐Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9458-5 · Cited by 99
for the LifeWindows Team, Fisher, J. D., Amico, K. R., Fisher, W. A., Cornman, D. H., Shuper, P. A., Trayling, C., Redding, C. G., Barta, W. D., Lemieux, A. F., et al. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9926-x · Cited by 99
Sledjeski, E. M., Delahanty, D. L., & Bogart, L. M. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.728 · Cited by 98
Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9293-5 · Cited by 99
“Participants completed the Medication Use and Adherence Questionnaire developed by the AIDS Clinical Trials Group Study 359 (Chesney et al. 2000; Fletcher et al. 2005).”
MethodModeling the effects of spirituality/religion on patients’ perceptions of living with HIV/AIDS
Szaflarski, M., Ritchey, P. N., Leonard, A. C., Mrus, J. M., Peterman, A. H., Ellison, C. G., McCullough, M. E., & Tsevat, J. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00646.x · Cited by 100
Woods, S. P., MORAN, L., Carey, C., DAWSON, M., Iudicello, J. E., Gibson, S. M., GRANT, I., & ATKINSON, J. (2008) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2007.12.006 · Cited by 98
“Per patient self-report, “forgetting” is among the most frequently perceived causes of missing antiretroviral (ARV) doses (Chesney et al., 2000).”
BackgroundResultMajor Depression in Patients with HIV/AIDS and Substance Abuse
Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G. R., Richardson, M. A., & Keane, T. M. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0153 · Cited by 98
Predictors of Antiretroviral Treatment Failure in an Urban HIV Clinic
Robbins, G. K., Daniels, B., Zheng, H. W., Chueh, H. C., Meigs, J. B., & Freedberg, K. A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248351.10383.b7 · Cited by 97
Halkitis, P. N., Parsons, J. T., Wolitski, R. J., & Remien, R. H. (2003) · AIDS Care · doi:10.1080/095401221000039798 · Cited by 96
Sangeda, R. Z., Mosha, F. S., Prosperi, M., Aboud, S., Vercauteren, J., Camacho, R. J., Lyamuya, E., Wijngaerden, E. V., & Vandamme, A. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1035 · Cited by 96
Adherence to Antiretroviral Therapy Among HIV-Infected Adults in the United States
Beer, L., & Skarbinski, J. (2014) · AIDS Education and Prevention · doi:10.1521/aeap.2014.26.6.521 · Cited by 95
“We estimated the prevalence of self-reported 100% adherence to ART doses (dose adherence) in the past 3 days using AIDS Clinical Trials Group measures (Chesney et al., 2000).”
Community-Based Participatory Research
Springer, M. V., & Skolarus, L. E. (2019) · Stroke · doi:10.1161/strokeaha.118.024241 · Cited by 99
Predictors of Antiretroviral Medication Adherence Among a Diverse Cohort of Adolescents With HIV
Chandwani, S., Koenig, L. J., Sill, A. M., Abramowitz, S., Conner, L. C., & D’Angelo, L. J. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2011.12.013 · Cited by 95
Carrieri, P., Raffi, F., Lewden, C., Sobel, A. T., Michelet, C., Cailleton, V., Chêne, G., Leport, C., Moatti, J., Spire, B., et al. (2003) · Antiviral Therapy · doi:10.1177/135965350300800606 · Cited by 95
“Five questions regarding adherence to HAART were included in all self-administered questionnaires according to the methodology established by the AIDS Clinical Trial Group [10].”
MethodFord, N. P., Darder, M., Spelman, T. D., Maclean, E., Mills, E. J., & Boulle, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010460 · Cited by 94
“The adherence survey included all consenting patients enrolled onto antiretroviral therapy at primary care clinics in Khayelitshsa township, South Africa between May 2002 and March 2004. Self-reported adherence was assessed by a dedicated study team unrelated to the provision of clinical care using a modified version…”
MethodTaiwo, B., Zheng, L., Stefanescu, A. R., Nyaku, A. N., Bezins, B., Wallis, C. L., Godfrey, C. C., Sax, P. E., Acosta, E. P., Haas, D. W., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1083 · Cited by 93
Delahanty, D. L., Bogart, L. M., & Figler, J. L. (2003) · AIDS Care · doi:10.1080/09540120410001641084 · Cited by 93
Ironson, G. H., O’Cleirigh, C. M., Weiß, A., Schneiderman, N., & Costa, P. T. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816422fc · Cited by 93
“Adherence Prescribed medications and adherence were assessed through interviewer administered AIDS Clinical Trials Group Adherence Measure (34).”
MethodDeterminants of HAART discontinuation among injection drug users
Kerr, T. H., Marshall, A., Walsh, J. C., Palepu, A., TYNDALL, M. W., Montaner, J. S. G., Hogg, R. S., & Wood, E. (2005) · AIDS Care · doi:10.1080/09540120412331319778 · Cited by 93
Smartphone Self-Monitoring to Support Self-Management Among People Living With HIV
Swendeman, D. T., Ramanathan, N., Baetscher, L., Medich, M., Scheffler, A., Comulada, W. S., & Estrin, D. L. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000570 · Cited by 90
Development and validation of the Beliefs and Behaviour Questionnaire (BBQ)
George, J., Mackinnon, A. J., Kong, D. C. M., & Stewart, K. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2005.11.010 · Cited by 92
de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R. N., & Israelski, D. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00008 · Cited by 92
Gonzalez, J. S., Hendriksen, E., Collins, E. M., Durán, R. E., & Safren, S. A. (2008) · AIDS and Behavior · doi:10.1007/s10461-008-9402-4 · Cited by 97
Arnsten, J. H., Li, X., Mizuno, Y., Knowlton, A. R., Gourevitch, M. N., Handley, K., Knight, K. R., & Metsch, L. R. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815767d6 · Cited by 90
Steele, R. G., & Grauer, D. W. (2003) · Clinical Child and Family Psychology Review · doi:10.1023/a:1022261905640 · Cited by 90
Achaval, S. D., & Suarez-Almazor, M. E. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.15 · Cited by 90
Deschamps, A., Geest, S. D., Vandamme, A., Bobbaers, H., Peetermans, W. E., & Wijngaerden, E. V. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2007.0229 · Cited by 90
“7 Only four self-report questionnaires—the simplified medication adherence questionnaire (SMAQ), 16 the visual analogue scale (VAS), 17 the Adult AIDS Clinical Trials Group (AACTG) questionnaire, 18 and the Self-Reported Adherence (SERAD) 19 —have been validated against electronic monitoring.”
Wohl, A. R., Garland, W., Valencia, R., Squires, K., Witt, M. D., Kovács, A., Larsen, R. A., Hader, S., Anthony, M., & Weidle, P. J. (2006) · Clinical Infectious Diseases · doi:10.1086/503906 · Cited by 90
“Patients were interviewed by telephone by study staff not involved in the intervention 0, 3, and 6 months after enrollment; the interviews regarded selfreported adherence to HAART regimens in the previous 24 h, 3 days, and 7 days [21].”
MethodLi, X., Huang, L., Wang, H., Fennie, K., He, G., & Williams, A. B. (2011) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0174 · Cited by 89
The impact of illicit drug use and substance abuse treatment on adherence to HAART
Hicks, P. L., Mulvey, K. P., Chander, G., Fleishman, J. A., Josephs, J. S., Korthuis, P. T., Hellinger, J., Gaist, P., Gebo, K. A., & for the HIV Research Network (2007) · AIDS Care · doi:10.1080/09540120701351888 · Cited by 89
“(Chesney et al., 2000).”
Deering, K., Shannon, K., Sinclair, H., Parsad, D., Gilbert, E., & TYNDALL, M. W. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2009.0022 · Cited by 89
Telephone Support to Improve Antiretroviral Medication Adherence
Reynolds, N. R., Testa, M. A., Su, M., Chesney, M. A., Neidig, J. L., Frank, I., Smith, S. R., Ickovics, J. R., & Robbins, G. K. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181582d54 · Cited by 89
Self-citationEvaluation of WebEase: an epilepsy self-management Web site
DiIorio, C. K., Escoffery, C., McCarty, F., Yeager, K. A., Henry, T. R., Koganti, A., Reisinger, E. L., & Wexler, B. (2008) · Health Education Research · doi:10.1093/her/cyn012 · Cited by 89
“‘Self-report adherence’ was measured using the 15-item USCF Adherence Questionnaire and the five-item Antiretroviral General Adherence Scale (AGAS), both of which were developed for use with other medications and revised for use with antiepileptic drugs [30, 31].”
MethodTowfighi, A., Cheng, E. M., Ayala-Rivera, M., Barry, F., McCreath, H. E., Ganz, D. A., Lee, M. L., Sanossian, N., Mehta, B. K., Dutta, T. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.36227 · Cited by 87
Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy
Marra, C. M., Maxwell, C. L., Collier, A. C., Robertson, K. R., & Imrie, A. A. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-37 · Cited by 88
“At each visit, they underwent a standardized neurological and medication history; neurological examination; brief neuropsychological test battery that included timed gait, grooved pegboard with the dominant hand, finger tapping with the nondominant hand and digit symbol; assessment of antiretroviral drug adherence [8]…”
MethodUnge, C., Södergård, B., Marrone, G., Thorson, A. E., Lukhwaro, A., Carter, J. Y., Ilako, F., & Ekström, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013613 · Cited by 87
“The follow-up questionnaire focused on self-reported adherence to ART (as measured by a modified AACTG questionnaire [23]).”
BackgroundMethodInfluentialElul, B., Basinga, P., Nuwagaba‐Biribonwoha, H., Saito, S., Horowitz, D., Nash, D., Mugabo, J., Mugisha, V., Rugigana, E., Nkunda, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053586 · Cited by 87
Testing a peer-based symptom management intervention for women living with HIV/AIDS
Webel, A. R. (2010) · AIDS Care · doi:10.1080/09540120903214389 · Cited by 87
“The ACTGrev is a self-report measure of reasons for missing medications (Chesney et al., 2000; Holzemer et al., 2006).”
BackgroundTesting a Nurse-Tailored HIV Medication Adherence Intervention
Holzemer, W. L., Henry, S. B., Portillo, C. J., Grimes, R., Welch, J., Wantland, D. J., & Mullan, J. T. (2006) · Nursing Research · doi:10.1097/00006199-200605000-00005 · Cited by 86
“’’ Evidence for the construct validity of ACTGRev as a whole has been established (Chesney et al., 2000), but no validity and reliability information related specifically to the reasons for missing medication scale was reported.”
BackgroundInfluentialPeretti‐Watel, P., Spire, B., Pierret, J., Lert, F., Obadia, Y., & The VESPA Group (2006) · AIDS Care · doi:10.1080/09540120500456193 · Cited by 87
“Previous studies found that not wanting others to see one taking medication is often reported as a reason for missing doses (Chesney et al., 2000; Gifford et al., 2000), and a few quantitative studies have concluded that nonadherence to HAART was positively correlated to concealment of one’s…”
BackgroundWagner, G. J., & Ryan, G. W. (2004) · AIDS Patient Care and STDs · doi:10.1089/1087291041518238 · Cited by 87
Predictors of Self-Reported Antidepressant Adherence
Burra, T. A., Chen, E., McIntyre, R. S., Grace, S. L., Blackmore, E. R., & Stewart, D. E. (2007) · Behavioral Medicine · doi:10.3200/bmed.32.4.127-134 · Cited by 86
Spiritual coping predicts CD4-cell preservation and undetectable viral load over four years
Kremer, H., Ironson, G. H., Kaplan, L. M., Stuetzele, R., Baker, N., & FLETCHER, M. A. (2014) · AIDS Care · doi:10.1080/09540121.2014.952220 · Cited by 86
“We assessed taking/adhering to ART with the adherence questionnaire of the AIDS Clinical Trials Group (Chesney et al., 2000).”
MethodDenison, J., Koole, O., Tsui, S., Menten, J., Torpey, K., van Praag, E., Mukadi, Y., Colebunders, R., Auld, A., Agolory, S., et al. (2015) · AIDS (London) · doi:10.1097/qad.0000000000000543 · Cited by 86
“Participants reported their 3-day adherence using the Adult AIDS Clinical Trials Group (AACTG) measure specifying the numbers of tablets for each drug missed each day [21], followed by an aggregate question of how many ART tablets missed in the previous 30 days.”
the HIVIND study team, Costa, A. D., Shet, A., Kumarasamy, N., Ashorn, P., Eriksson, B., Bogg, L., & Diwan, V. K. (2010) · BMC Medical Research Methodology · doi:10.1186/1471-2288-10-25 · Cited by 88
Deschamps, A., Graeve, V. D., Wijngaerden, E. V., Saar, V. D., Vandamme, A., Vaerenbergh, K. V., Ceunen, H., Bobbaers, H., Peetermans, W. E., Vleeschouwer, P. D., et al. (2004) · AIDS Patient Care and STDs · doi:10.1089/apc.2004.18.644 · Cited by 85
“71 Clear instructions about how to take medicines, 55,72 adequate knowledge about the relationship between adherence and viral load 27,30,44 and better medical follow-up, 27,42,69 are all related to better adherence.”
InfluentialBogart, L. M., Bird, S. T., Walt, L. C., Delahanty, D. L., & Figler, J. L. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(03)00277-6 · Cited by 87
Kalichman, S. C. (2004) · Health Education Research · doi:10.1093/her/cyg106 · Cited by 83
Depression in patients with HIV is under‐diagnosed: a cross‐sectional study in Denmark
Rodkjær, L. Ø., Laursen, T. L., Balle, N., & Sodemann, M. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00741.x · Cited by 84
Hanna, D. B., Hessol, N. A., Golub, E. T., Cocohoba, J. M., Cohen, M. H., Levine, A. M., Wilson, T. E., Young, M., Anastos, K., & Kaplan, R. C. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000082 · Cited by 84
“ART adherence is assessed in the WIHS by asking the participant the percentage of time during the past 6 months that ART was taken as prescribed,(26) categorized as: 100% of the time, 95–99%, 75–94%, and 75%.”
MethodInfluentialIronson, G. H., O’Cleirigh, C. M., Kumar, M., Kaplan, L. M., Balbin, E., Kelsch, C. B., Fletcher, M. A., & Schneiderman, N. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0877-x · Cited by 87
“adherence was assessed through interviewer administered AIDS Clinical Trials Group Adherence measure [47].”
Adherence to HIV antiretroviral therapy
Heyer, A., & Ogunbanjo, G. A. (2006) · South African Family Practice · doi:10.1080/20786204.2006.10873433 · Cited by 84
Cohort Profile: The Ontario HIV Treatment Network Cohort Study (OCS)
Rourke, S. B., Gardner, S. L., Burchell, A. N., Raboud, J., Rueda, S., Bayoumi, A. M., Loutfy, M. R., Cooper, C., Smieja, M., Taylor, D., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr230 · Cited by 84
Violence, Coping, and Consistent Medication Adherence in HIV-Positive Couples
Lopez, E. J., Jones, D. L., Villar-Loubet, O. M., Arheart, K. L., & Weiss, S. M. (2010) · AIDS Education and Prevention · doi:10.1521/aeap.2010.22.1.61 · Cited by 84
“ACTG Questionnaire for Adherence to Anti-HIV Medications—Adherence was measured by 4-day self-report using the ACTG (AIDS Clinical Trials Group) Questionnaire for Adherence to Anti-HIV Medications (4 days; Chesney et al., 2000).”
MethodSwindells, S. (2006) · JAMA · doi:10.1001/jama.296.7.806 · Cited by 84
Cohen, K., Grant, A. D., Dandara, C., McIlleron, H., Pemba, L., Fielding, K., Charalombous, S., Churchyard, G., Smith, P. J., & Maartens, G. (2009) · PubMed · Cited by 83
Safren, S. A., Kumarasamy, N., James, R., Raminani, S. R., Solomon, S., & Mayer, K. H. (2005) · AIDS Care · doi:10.1080/09540120500038439 · Cited by 83
“Catz et al, 2000 ; Chesney et al, 2000 ; Holzemer, et al, 2000 ), demographic variables were not associated with adherence in this study of patients in India.”
ResultHow Qualitative Methods Contribute to Understanding Combination Antiretroviral Therapy Adherence
Sankar, A., Golin, C. E., Simoni, J. M., LUBORSKY, M. R., & Pearson, C. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000248341.28309.79 · Cited by 83
Marconi, V. C., Grandits, G., Weintrob, A., Chun, H., Landrum, M. L., Ganesan, A., Okulicz, J. F., Crum‐Cianflone, N. F., O’Connell, R. J., Lifson, A. R., et al. (2010) · AIDS Research and Therapy · doi:10.1186/1742-6405-7-14 · Cited by 82
Okawa, S., Mwanza-Kabaghe, S., Mwiya, M., Kikuchi, K., Jimba, M., Kankasa, C., & Ishikawa, N. (2018) · AIDS Care · doi:10.1080/09540121.2018.1425364 · Cited by 83
“We utilized “self-report” in measuring adherence to ART (Chesney et al., 2000).”
MethodGebo, K. A., Keruly, J. C., & Moore, R. D. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.10801.x · Cited by 82
Patient Reported Outcomes in Routine Care: Advancing Data Capture for HIV Cohort Research
Kozak, M. S., Mugavero, M. J., Ye, J., Aban, I., Lawrence, S. T., Nevin, C. R., Raper, J. L., McCullumsmith, C. B., Schumacher, J. E., Crane, H. M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir727 · Cited by 82
Antiretroviral Concentrations in Small Hair Samples as a Feasible Marker of Adherence in Rural Kenya
Hickey, M. D., Salmen, C. R., Tessler, R. A., Omollo, D. O., Bacchetti, P., Magerenge, R., Mattah, B. J., Salmen, M. R., Zoughbie, D. E., Fiorella, K. J., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000154 · Cited by 83
Schneider, M., Chersich, M., Temmerman, M., & Parry, C. D. H. (2016) · Globalization and Health · doi:10.1186/s12992-016-0201-9 · Cited by 82
“The Adult AIDS Clinical Trials Group, [11] an instrument for measuring levels of adherence to ART and reasons for missed doses, was not used to analyse the transcripts but could be considered for use in future research in this area focusing on adherence measurement.”
MethodPill taking ‘routinization’: a critical factor to understanding episodic medication adherence
Ryan, G. W., & Wagner, G. J. (2003) · AIDS Care · doi:10.1080/09540120310001618649 · Cited by 81
Chandler, R. K., Kahana, S. Y., Fletcher, B. W., Jones, D. J., Finger, M. S., Aklin, W. M., Hamill, K., & Webb, C. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302788 · Cited by 80
Medication Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes
da Conceição, V. A., Rocha, K. S. S., Silva, F. V. N., Silva, R. D. O. S., da Silva, D. T., & de Lyra, D. P. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018773691 · Cited by 80
Giacomet, V., Albano, F., Starace, F., de Franciscis, A., Giaquinto, C., Gattinara, G. C., Bruzzese, E., Gabiano, C., Galli, L., Viganò, M., et al. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00822.x · Cited by 80
“Since adherence rates 95% of prescribed doses have been associated with optimal virological outcome (13), children were defined as adherent if they had taken no less than 95% of all prescribed doses of antiretroviral therapy in the past 4 d (9, 14).”
BackgroundSullivan, P. S., Campsmith, M., Nakamura, G. V., Begley, E. B., Schulden, J. D., & Nakashima, A. K. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000552 · Cited by 80
Behavioral Aspects of HIV Care: Adherence, Depression, Substance Use, and HIV-Transmission Behaviors
Berg, C. J., Michelson, S. E., & Safren, S. A. (2007) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.01.005 · Cited by 81
HIV Stigma Among Substance Abusing People Living with HIV/AIDS: Implications for HIV Treatment
Levi-Minzi, M. A., & Surratt, H. L. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0076 · Cited by 80
Medication Adherence in Psychopharmacologically Treated Adults With ADHD
Safren, S. A., Duran, P., Yovel, I., Perlman, C. A., & Sprich, S. (2007) · Journal of Attention Disorders · doi:10.1177/1087054706292165 · Cited by 81
“Adherence was assessed using a modified version of the adherence questionnaire for HIV/AIDS that is used by the AIDS Clinical Trials Group (Chesney et al., 2000) that we (Safren et al., 2001) and others have successfully implemented in HIV research.”
MethodWhetten, K., Shirey, K., Pence, B. W., Yao, J., Thielman, N. M., Whetten, R., Adams, J., Agala, C. B., Ostermann, J., O’Donnell, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074771 · Cited by 81
Boyd, M. A., Moore, C. L., Molina, J., Wood, R., Madero, J. S., Wolff, M. J., Ruxrungtham, K., Losso, M. H., Renjifo, B., Teppler, H., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(14)00061-7 · Cited by 79
Monnette, A. M., Zhang, Y., Shao, H., & Shi, L. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0570-9 · Cited by 84
“The AACTG instrument was developed by the AIDS Clinical Trials Group (ACTG) Recruitment, Adherence and Retention Subcommittee for HIV populations [27].”
MethodTreatment-Related Factors and Highly Active Antiretroviral Therapy Adherence
Trotta, M. P., Ammassari, A., Melzi, S., Zaccarelli, M., Ladisa, N., Sighinolfi, L., Mura, M. S., Monforte, A. D., & Antinori, A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00008 · Cited by 79
Is Patients’ Preferred Involvement in Health Decisions Related to Outcomes for Patients with HIV?
Beach, M. C., Duggan, P. S., & Moore, R. D. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0241-1 · Cited by 78
Metadata
- Authors
- Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE
- Affiliations
- University of California, San Francisco (US)
- Yale University (US)
- University of California San Diego (US)
- The Ohio State University (US)
- Indiana University Indianapolis (US)
- Johns Hopkins University (US)
- Venue
- AIDS Care
- Publisher
- Informa UK Limited
- Published
- 2000-06
- Volume
- 12
- Issue
- 3
- Pages
- 255-266
- ISSN
- 0954-0121 (ISSN-L)
- 1360-0451
- OpenAlex
- W2088423598
- Cited by
- 1,428
- References
- 12
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 29 · 2023: 29 · 2022: 40 · 2021: 53 · 2020: 51 · 2019: 55 · 2018: 61 · 2017: 66 · 2016: 67 · 2015: 76 · 2014: 81 · 2013: 84 · 2012: 74
- FWCI
- 27.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (P50-MH42459, P30MH059037, P50MH042459, P30-MH 59037)
- National Institute of Allergy and Infectious Diseases (U01AI-38858, U01AI038858)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- antiretroviral therapy adherence, HIV, self-report questionnaire, medication non-adherence, adherence self-efficacy, alcohol consumption, protease inhibitors, clinical trial participants, questionnaire development
- MeSH terms
- Adult, Alcohol Drinking, Clinical Trials as Topic, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Compliance, Pilot Projects, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, HIV Infections, Anti-HIV Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review